
Robert A. Zeman
Examiner (ID: 12430, Phone: (571)272-0866 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1643 |
| Total Applications | 1326 |
| Issued Applications | 557 |
| Pending Applications | 268 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13413701
[patent_doc_number] => 20180258393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/981332
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981332
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/981332 | Method for ex-vivo expansion of regulatory T cells with enhanced suppressive function for clinical application in immune mediated diseases | May 15, 2018 | Issued |
Array
(
[id] => 13447167
[patent_doc_number] => 20180275126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => POLYVALENT CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN
[patent_app_type] => utility
[patent_app_number] => 15/976938
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15976938
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/976938 | Polyvalent chimeric OspC vaccinogen and diagnostic antigen | May 10, 2018 | Issued |
Array
(
[id] => 20157011
[patent_doc_number] => 12383609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Plasmodium sporozoite NPDP peptides as vaccine and target novel malaria vaccines and antibodies binding to
[patent_app_type] => utility
[patent_app_number] => 16/606207
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 53821
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606207 | Plasmodium sporozoite NPDP peptides as vaccine and target novel malaria vaccines and antibodies binding to | Apr 18, 2018 | Issued |
Array
(
[id] => 13374617
[patent_doc_number] => 20180238850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => DETECTION METHOD
[patent_app_type] => utility
[patent_app_number] => 15/956315
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956315
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/956315 | DETECTION METHOD | Apr 17, 2018 | Abandoned |
Array
(
[id] => 13986507
[patent_doc_number] => 20190062411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => MRKA POLYPEPTIDES, ANTIBODIES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/940344
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15940344
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/940344 | MRKA POLYPEPTIDES, ANTIBODIES, AND USES THEREOF | Mar 28, 2018 | Abandoned |
Array
(
[id] => 13462565
[patent_doc_number] => 20180282825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => PROBIOTIC BIFIDOBACTERIUM STRAIN
[patent_app_type] => utility
[patent_app_number] => 15/936661
[patent_app_country] => US
[patent_app_date] => 2018-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15936661
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/936661 | Probiotic bifidobacterium strain | Mar 26, 2018 | Issued |
Array
(
[id] => 16748843
[patent_doc_number] => 20210100852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => Novel Bifidobacterium Genus Bacterium
[patent_app_type] => utility
[patent_app_number] => 16/498148
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498148
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498148 | None | Mar 22, 2018 | Issued |
Array
(
[id] => 15557509
[patent_doc_number] => 20200063166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => ZINC BINUCLEAR CLUSTER TRANSCRIPTIONAL REGULATOR-DEFICIENT STRAIN
[patent_app_type] => utility
[patent_app_number] => 16/493017
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 317
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493017
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493017 | ZINC BINUCLEAR CLUSTER TRANSCRIPTIONAL REGULATOR-DEFICIENT STRAIN | Mar 11, 2018 | Abandoned |
Array
(
[id] => 18732572
[patent_doc_number] => 11801292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Polypeptide epitopes of
[patent_app_type] => utility
[patent_app_number] => 16/486937
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 10295
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486937 | Polypeptide epitopes of | Feb 15, 2018 | Issued |
Array
(
[id] => 15254195
[patent_doc_number] => 20190375831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/485354
[patent_app_country] => US
[patent_app_date] => 2018-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485354
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485354 | Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use | Feb 11, 2018 | Issued |
Array
(
[id] => 16893202
[patent_doc_number] => 11034735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits
[patent_app_type] => utility
[patent_app_number] => 16/485035
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22556
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485035
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485035 | Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits | Feb 8, 2018 | Issued |
Array
(
[id] => 18302054
[patent_doc_number] => 11623945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Immunostimulating compositions and uses therefore
[patent_app_type] => utility
[patent_app_number] => 16/483806
[patent_app_country] => US
[patent_app_date] => 2018-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34430
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483806 | Immunostimulating compositions and uses therefore | Feb 5, 2018 | Issued |
Array
(
[id] => 14810175
[patent_doc_number] => 20190271697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => Modified Indirect Enzyme Linked Immunosorbent Assay Optimal for Monitoring Acute and Long Term Carrier Infections of Diverse Babesia bovis Strains
[patent_app_type] => utility
[patent_app_number] => 15/886915
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886915
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/886915 | Modified Indirect Enzyme Linked Immunosorbent Assay Optimal for Monitoring Acute and Long Term Carrier Infections of Diverse Babesia bovis Strains | Feb 1, 2018 | Abandoned |
Array
(
[id] => 12908935
[patent_doc_number] => 20180194820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/883999
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15883999
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/883999 | Anti-inflammatory compounds and methods of use | Jan 29, 2018 | Issued |
Array
(
[id] => 15296021
[patent_doc_number] => 20190391146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => Methods of Detecting and Diagnosing Tuberculosis Using Anti-MTLDL Antibodies
[patent_app_type] => utility
[patent_app_number] => 16/481025
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481025
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481025 | Methods of Detecting and Diagnosing Tuberculosis Using Anti-MTLDL Antibodies | Jan 24, 2018 | Abandoned |
Array
(
[id] => 17192124
[patent_doc_number] => 11160856
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Vaccine against
[patent_app_type] => utility
[patent_app_number] => 15/878491
[patent_app_country] => US
[patent_app_date] => 2018-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 12415
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878491
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/878491 | Vaccine against | Jan 23, 2018 | Issued |
Array
(
[id] => 15345247
[patent_doc_number] => 20200010515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => RECOMBINANT VACCINE AGAINST HELMINTHS IN PICHIA PASTORIS AND METHODS FOR PRODUCING AND PURIFYING PROTEINS FOR USE AS VACCINES AGAINST HELMINTHS
[patent_app_type] => utility
[patent_app_number] => 16/478521
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478521
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478521 | RECOMBINANT VACCINE AGAINST HELMINTHS IN PICHIA PASTORIS AND METHODS FOR PRODUCING AND PURIFYING PROTEINS FOR USE AS VACCINES AGAINST HELMINTHS | Jan 21, 2018 | Abandoned |
Array
(
[id] => 13490227
[patent_doc_number] => 20180296656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => CHIMERIC OSPA GENES, PROTEINS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/875479
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875479
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/875479 | Chimeric OspA genes, proteins and methods of use thereof | Jan 18, 2018 | Issued |
Array
(
[id] => 12750439
[patent_doc_number] => 20180141980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => TREPONEMA PALLIDUM TRIPLET ANTIGEN
[patent_app_type] => utility
[patent_app_number] => 15/865594
[patent_app_country] => US
[patent_app_date] => 2018-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15865594
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/865594 | Treponema pallidum triplet antigen | Jan 8, 2018 | Issued |
Array
(
[id] => 17177374
[patent_doc_number] => 11154603
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-10-26
[patent_title] => Burkholderia pseudomallei composition
[patent_app_type] => utility
[patent_app_number] => 15/864268
[patent_app_country] => US
[patent_app_date] => 2018-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4882
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15864268
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/864268 | Burkholderia pseudomallei composition | Jan 7, 2018 | Issued |